Kimiharu Uozumi

2.0k total citations
63 papers, 1.3k citations indexed

About

Kimiharu Uozumi is a scholar working on Immunology, Ecology, Evolution, Behavior and Systematics and Agronomy and Crop Science. According to data from OpenAlex, Kimiharu Uozumi has authored 63 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Immunology, 31 papers in Ecology, Evolution, Behavior and Systematics and 19 papers in Agronomy and Crop Science. Recurrent topics in Kimiharu Uozumi's work include T-cell and Retrovirus Studies (47 papers), Vector-Borne Animal Diseases (31 papers) and Animal Disease Management and Epidemiology (19 papers). Kimiharu Uozumi is often cited by papers focused on T-cell and Retrovirus Studies (47 papers), Vector-Borne Animal Diseases (31 papers) and Animal Disease Management and Epidemiology (19 papers). Kimiharu Uozumi collaborates with scholars based in Japan, United States and Greece. Kimiharu Uozumi's co-authors include Atae Utsunomiya, Shuichi Hanada, Terukatsu Arima, Kunihiro Tsukasaki, Kazunari Yamaguchi, Shinsuke Suzuki, Naomichi Arima, Kenji Ishitsuka, Ryuzo Ueda and Naokuni Uike and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Kimiharu Uozumi

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimiharu Uozumi Japan 15 892 557 516 220 202 63 1.3k
Shinichiro Yoshida Japan 16 709 0.8× 346 0.6× 256 0.5× 208 0.9× 218 1.1× 65 1.2k
Tomoko Hata Japan 22 681 0.8× 444 0.8× 380 0.7× 156 0.7× 387 1.9× 96 1.5k
Mitsuo Kozuru Japan 16 563 0.6× 310 0.6× 214 0.4× 340 1.5× 322 1.6× 58 1.2k
Koichiro Suemori Japan 14 383 0.4× 182 0.3× 190 0.4× 101 0.5× 112 0.6× 38 665
K Takatsuki Japan 15 499 0.6× 287 0.5× 283 0.5× 79 0.4× 142 0.7× 23 727
Kusuki Nishioka Japan 9 459 0.5× 108 0.2× 144 0.3× 211 1.0× 252 1.2× 13 994
Ryosuke Hino Japan 14 622 0.7× 97 0.2× 58 0.1× 592 2.7× 114 0.6× 30 1.1k
Tomonori Hidaka Japan 15 174 0.2× 88 0.2× 65 0.1× 97 0.4× 210 1.0× 43 565
Kiyoshi Takatsuki Japan 11 345 0.4× 176 0.3× 181 0.4× 45 0.2× 93 0.5× 19 507

Countries citing papers authored by Kimiharu Uozumi

Since Specialization
Citations

This map shows the geographic impact of Kimiharu Uozumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimiharu Uozumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimiharu Uozumi more than expected).

Fields of papers citing papers by Kimiharu Uozumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimiharu Uozumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimiharu Uozumi. The network helps show where Kimiharu Uozumi may publish in the future.

Co-authorship network of co-authors of Kimiharu Uozumi

This figure shows the co-authorship network connecting the top 25 collaborators of Kimiharu Uozumi. A scholar is included among the top collaborators of Kimiharu Uozumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimiharu Uozumi. Kimiharu Uozumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tokunaga, Masahito, Kimiharu Uozumi, Yasuko Sagara, et al.. (2023). A decrease in newly diagnosed patients with adult T-cell leukemia/lymphoma in Kagoshima, a highly endemic area of HTLV-1 in southwestern Japan. Leukemia & lymphoma. 64(4). 865–873. 1 indexed citations
2.
Takamatsu, Yasushi, Kazutaka Sunami, Tsuyoshi Muta, et al.. (2013). Bortezomib, doxorubicin and intermediate-dose dexamethasone (iPAD) therapy for relapsed or refractory multiple myeloma: a multicenter phase 2 study. International Journal of Hematology. 98(2). 179–185. 8 indexed citations
3.
Nakamura, Tomonori, et al.. (2012). Vincristine exacerbates asymptomatic Charcot–Marie–Tooth disease with a novel EGR2 mutation. Neurogenetics. 13(1). 77–82. 38 indexed citations
4.
Kozako, Tomohiro, Masaki Akimoto, Shingo Toji, et al.. (2011). Target epitopes of HTLV‐1 recognized by class I MHC‐restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders. Journal of Medical Virology. 83(3). 501–509. 16 indexed citations
5.
Iwanaga, Masako, Toshiki Watanabe, Atae Utsunomiya, et al.. (2010). Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 116(8). 1211–1219. 255 indexed citations
6.
Takamatsu, Yasushi, Kazutaka Sunami, Hiroyuki Hata, et al.. (2010). A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma. International Journal of Hematology. 92(3). 503–509. 6 indexed citations
7.
Otsuka, Maki, et al.. (2008). Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma. International Journal of Hematology. 89(2). 188–194. 3 indexed citations
8.
Akimoto, Masaki, Tomohiro Kozako, Takashi Sawada, et al.. (2007). Anti‐HTLV‐1 tax antibody and tax‐specific cytotoxic T lymphocyte are associated with a reduction in HTLV‐1 proviral load in asymptomatic carriers. Journal of Medical Virology. 79(7). 977–986. 28 indexed citations
9.
Arima, Naomichi, Kakushi Matsushita, Kimiharu Uozumi, et al.. (2007). Cyclosporin a inhibits HTLV‐I tax expression and shows anti‐tumor effects in combination with VP‐16. Journal of Medical Virology. 79(12). 1906–1913. 8 indexed citations
10.
Kozako, Tomohiro, Naomichi Arima, Shingo Toji, et al.. (2006). Reduced Frequency, Diversity, and Function of Human T Cell Leukemia Virus Type 1-Specific CD8+ T Cell in Adult T Cell Leukemia Patients. The Journal of Immunology. 177(8). 5718–5726. 60 indexed citations
11.
Utsunomiya, Atae, Mitsutoshi Tara, Masayoshi Tokunaga, et al.. (2006). A Family Predisposition to Adult T-Cell Leukemia. Journal of Clinical and Experimental Hematopathology. 46(2). 67–71. 4 indexed citations
12.
Tani, Ayako, Kimiharu Uozumi, Shuichi Hanada, et al.. (2001). Expression of functional lung resistance–related protein predicts poor outcome in adult T-cell leukemia. Blood. 98(4). 1160–1165. 52 indexed citations
13.
Uozumi, Kimiharu, Y Takatsuka, Torahiko Makino, et al.. (1998). Granulocyte Colony-Stimulating Factor in the Combination Chemotherapy for Adult T-Cell Leukemia (ATL). Leukemia & lymphoma. 29(3-4). 407–414. 7 indexed citations
14.
Utsunomiya, Atae, Shuichi Hanada, Kimiharu Uozumi, et al.. (1998). Transient appearance of CD3+CD8+ T lymphocytes with monoclonal gene rearrangement of T‐cell receptor β locus. British Journal of Haematology. 100(2). 411–414. 10 indexed citations
15.
Uozumi, Kimiharu, et al.. (1997). Isolated choroidal leukemic infiltration during complete remission. American Journal of Hematology. 55(3). 164–165. 3 indexed citations
16.
Uozumi, Kimiharu, T. Uematsu, Maki Otsuka, et al.. (1996). Serum dehydroepiandrosterone and DHEA-sulfate in patients with adult T-cell leukemia and human T-lymphotropic virus type I carriers. American Journal of Hematology. 53(3). 165–168. 7 indexed citations
17.
Uozumi, Kimiharu, Shuichi Hanada, Kenji Ishitsuka, et al.. (1995). Combination Chemotherapy (RCM Protocol: Response-Oriented Cyclic Multidrug Protocol) For the Acute or Lymphoma Type Adult T-cell Leukemia. Leukemia & lymphoma. 18(3-4). 317–323. 26 indexed citations
18.
Uozumi, Kimiharu, et al.. (1994). Elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T‐cell leukaemia complicated with meningeal infiltration. British Journal of Haematology. 87(3). 643–646. 3 indexed citations
19.
Heneine, Walid, et al.. (1991). HTLV-II and HTLV-I associated myelopathy. The Lancet. 338(8772). 944–945. 5 indexed citations
20.
Kuwazuru, Yasuo, Akihiko Yoshimura, Shuichi Hanada, et al.. (1990). Expression of the multidrug transporter, P‐glycoprotein, in chronic myelogenous leukaemia cells in blast crisis. British Journal of Haematology. 74(1). 24–29. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinichiro Yoshida Breakdown of academic impact, for papers by Tomoko Hata Breakdown of academic impact, for papers by Mitsuo Kozuru Breakdown of academic impact, for papers by Koichiro Suemori Breakdown of academic impact, for papers by K Takatsuki Breakdown of academic impact, for papers by Kusuki Nishioka Breakdown of academic impact, for papers by Ryosuke Hino Breakdown of academic impact, for papers by Tomonori Hidaka Breakdown of academic impact, for papers by Kiyoshi Takatsuki
Rankless by CCL
2026